Evidence map›Paper›PMID 25781172›Full record

ArticlePloS one2015

Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation.

Dimitrios Avramopoulos, Brad D Pearce, John McGrath, Paula Wolyniec, Ruihua Wang, Nicole Eckart, Alexandros Hatzimanolis, Fernando S Goes, Gerald Nestadt, Jennifer Mulle and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 3 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 3 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. A review of post-GWAS studies in schizophrenia.Translational psychiatry · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Therapeutic Implications of the Microbial Hypothesis of Mental Illness.Current topics in behavioral neurosciences · 2023
    Review
  14. Article
  15. Toll-Like Receptor (Neuropsychiatric disease and treatment · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Dimitrios AvramopoulosMcKusick Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America; Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Brad D PearceDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America.
John McGrathDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Paula WolyniecDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Ruihua WangDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Nicole EckartMcKusick Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Alexandros HatzimanolisDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Fernando S GoesDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Gerald NestadtDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Jennifer MulleDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America.
Karen ConeelyDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States of America.
Myfanwy HopkinsDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America.
Ingo RuczinskiBloomberg School of Public Heath, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Robert YolkenDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Ann E PulverDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Johns Hopkins University · USJohns Hopkins Medicine · USEmory University · US

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
Predoctoral Training Program in Human GeneticsT32GM007814 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 1985 to 2021
$10.6M
A Genome Wide SNP Association Study: SchizophreniaR01MH068406 · NIMH · JOHNS HOPKINS UNIVERSITY · PI PULVER, ANN E · 2004 to 2007
$3.7M
HETEROGENEITY OF BIPOLAR DISORDERR01MH058153 · NIMH · JOHNS HOPKINS UNIVERSITY · PI PULVER, ANN E · 1999 to 2003
$3.3M
Identification of genetic determinants of schizophrenia related phenotypesR01MH085018 · NIMH · JOHNS HOPKINS UNIVERSITY · PI AVRAMOPOULOS, DIMITRIOS · 2010 to 2013
$2.5M
HETEROGENEITY OF SCHIZOPHRENIAR01MH057314 · NIMH · JOHNS HOPKINS UNIVERSITY · PI PULVER, ANN E · 1998 to 2001
$1.6M
1/2 Schizophrenia Heterogeneity and Toxoplasma ExposureR01MH092515 · NIMH · JOHNS HOPKINS UNIVERSITY · PI AVRAMOPOULOS, DIMITRIOS · 2011 to 2013
$1.0M
2/2 Schizophrenia Heterogeneity and Toxoplasma ExposureR01MH092512 · NIMH · EMORY UNIVERSITY · PI PEARCE, BRADLEY D · 2011 to 2013
$487k
NIGMS NIH HHS T32 GM007814NIMH NIH HHS MH057314NIMH NIH HHS MH058153NIMH NIH HHS MH068406NIMH NIH HHS MH085018NIMH NIH HHS MH092512NIMH NIH HHS MH092515NIMH NIH HHS MH094268NIMH NIH HHS P50 MH094268NIMH NIH HHS R01 MH058153NIMH NIH HHS R01 MH068406NIMH NIH HHS R01 MH085018NIMH NIH HHS R01 MH092512NIMH NIH HHS R01 MH092515
6 · The paper itself

Abstract

Inflammation and maternal or fetal infections have been suggested as risk factors for schizophrenia (SZ) and bipolar disorder (BP). It is likely that such environmental effects are contingent on genetic background. Here, in a genome-wide approach, we test the hypothesis that such exposures increase the risk for SZ and BP and that the increase is dependent on genetic variants. We use genome-wide genotype data, plasma IgG antibody measurements against Toxoplasma gondii, Herpes simplex virus type 1, Cytomegalovirus, Human Herpes Virus 6 and the food antigen gliadin as well as measurements of C-reactive protein (CRP), a peripheral marker of inflammation. The subjects are SZ cases, BP cases, parents of cases and screened controls. We look for higher levels of our immunity/infection variables and interactions between them and common genetic variation genome-wide. We find many of the antibody measurements higher in both disorders. While individual tests do not withstand correction for multiple comparisons, the number of nominally significant tests and the comparisons showing the expected direction are in significant excess (permutation p=0.019 and 0.004 respectively). We also find CRP levels highly elevated in SZ, BP and the mothers of BP cases, in agreement with existing literature, but possibly confounded by our inability to correct for smoking or body mass index. In our genome-wide interaction analysis no signal reached genome-wide significance, yet many plausible candidate genes emerged. In a hypothesis driven test, we found multiple interactions among SZ-associated SNPs in the HLA region on chromosome 6 and replicated an interaction between CMV infection and genotypes near the CTNNA3 gene reported by a recent GWAS. Our results support that inflammatory processes and infection may modify the risk for psychosis and suggest that the genotype at SZ-associated HLA loci modifies the effect of these variables on the risk to develop SZ.

Indexed as

Genetic VariationGenome-Wide Association StudyAntibodies, ProtozoanAntibodies, ViralBipolar DisorderCase-Control StudiesC-Reactive ProteinFemaleGenetic Predisposition to DiseaseHumansInflammationMaleParentsPolymorphism, Single NucleotideSchizophreniaToxoplasmaAntibodies, ProtozoanAntibodies, ViralC-Reactive Protein

Identifiers

PMID25781172
PMCPMC4363491
OpenAlexW1968703969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.